Jianhong Chu
Overview
Explore the profile of Jianhong Chu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sun X, Han Q, Luo H, Pan X, Ji Y, Yang Y, et al.
Sci Rep
. 2017 Mar;
7:43485.
PMID: 28266538
Mammalian cardiomyocytes undergo a critical hyperplastic-to-hypertrophic growth transition at early postnatal age, which is important in establishing normal physiological function of postnatal hearts. In the current study, we intended to...
12.
Zhao S, Zhang L, Han J, Chu J, Wang H, Chen X, et al.
ACS Nano
. 2016 May;
10(6):6189-200.
PMID: 27224853
Allogeneic transplantation of hematopoietic stem cells (HSC) in combination with T cells has a curative potential for hematopoietic malignancies through graft-versus-leukemia (GVL) effects, but is often compromised by the notorious...
13.
Zhu X, Liu Z, Liu J, Zhu J, Zhang J, Davis J, et al.
J Leukoc Biol
. 2016 Apr;
100(2):403-11.
PMID: 27106672
IL-27 is a heterodimeric cytokine that is composed of two subunits, i.e., EBV-induced gene 3 and IL-27p28 (also known as IL-30). Although the role of endogenous IL-27 in the pathogenesis...
14.
Chen X, Han J, Chu J, Zhang L, Zhang J, Chen C, et al.
Oncotarget
. 2016 Apr;
7(19):27764-77.
PMID: 27050072
Breast cancer brain metastases (BCBMs) are common in patients with metastatic breast cancer and indicate a poor prognosis. These tumors are especially resistant to currently available treatments due to multiple...
15.
Deng Y, Deng Y, He X, Chu J, Zhou J, Zhang Q, et al.
Sci Rep
. 2016 Feb;
6:21692.
PMID: 26877256
Studies involving the use of prenatally programmed hypertension have been shown to potentially contribute to prevention of essential hypertension (EH). Our previous research has demonstrated that prenatal inflammatory stimulation leads...
16.
Zhang L, Chu J, Yu J, Wei W
J Leukoc Biol
. 2015 Dec;
99(2):279-87.
PMID: 26643713
Graft-versus-host disease is a complication in patients undergoing hematopoietic stem cell transplantation. Graft-versus-host disease includes acute graft-versus-host disease and chronic graft-versus-host disease. Host APCs (e.g., dendritic cells and macrophages), effector...
17.
Han J, Chen X, Chu J, Xu B, Meisen W, Chen L, et al.
Cancer Res
. 2015 Dec;
75(24):5273-82.
PMID: 26631269
Oncolytic viruses, including oncolytic herpes simplex virus (oHSV), have produced provocative therapeutic responses in patients with glioblastoma, the most aggressive brain tumor. Paradoxically, innate immune responses mediated by natural killer...
18.
Han J, Chu J, Chan W, Zhang J, Wang Y, Cohen J, et al.
Sci Rep
. 2015 Jul;
5:11483.
PMID: 26155832
Glioblastoma (GB) remains the most aggressive primary brain malignancy. Adoptive transfer of chimeric antigen receptor (CAR)-modified immune cells has emerged as a promising anti-cancer approach, yet the potential utility of...
19.
Deng Y, Kerdiles Y, Chu J, Yuan S, Wang Y, Chen X, et al.
Immunity
. 2015 Mar;
42(3):457-70.
PMID: 25769609
Little is known about the role of negative regulators in controlling natural killer (NK) cell development and effector functions. Foxo1 is a multifunctional transcription factor of the forkhead family. Using...
20.
Deng Y, Chu J, Ren Y, Fan Z, Ji X, Mundy-Bosse B, et al.
J Immunol
. 2014 Aug;
193(6):2994-3002.
PMID: 25122922
Natural products are a major source for cancer drug development. NK cells are a critical component of innate immunity with the capacity to destroy cancer cells, cancer-initiating cells, and clear...